reThinking eHealth Webinar Announced: Hospital Marketing in the eHealth Era

... Register for the next reThinking eHealth Webinar on July 29th at 2pm EST/ 11am pst Birmingham, Ala. (PRWEB) July 19, 2009 -- In June of 2009, the world reached a turning point in our history. The Internet h...

Omnicell to Release Second Quarter 2009 Earnings Results on July 23

... call to download necessary audio software. Replay: Available starting at 2:30 p.m. PDT on July 23, 2009 through 8:59 p.m. pst on July 30. Dial 1-800-642-1687 within the U.S. and 1-706-645-9291 for all other locations, Conference ID # 20153924. Abo...

Z Trim Holdings Abstract Selected as 'Best of the Best' by Institute of Food Technologists

...resident of Manufacturing and Technology, Dr. Triveni Shukla, PhD., author of the abstract, will give an oral presentation in room 201AB at 11:50 a.m. pst on Tuesday, June 9 at the annual IFT meeting. In conformance with the requirements of the program, the IFT NPT judging subpanel recognized that ...

MessageSolution Releases SaaS Hosted Archiving Solution at Microsoft TechEd North America 2009

...;    • Outlook Web Access / Domino Web Access integration available         • pst Migration Tool         • Offline archive access         •...

reThinking eHealth Webinar: Will the Patient Centered Medical Home Be the Model for Universal Healthcare?

... Register for the next reThinking eHealth Webinar on April 29th at 2pm EST/ 11am pst (PRWEB) April 19, 2009 -- What is a Patient Centered Medical Home? Why do hospital executives across North America think ha...

Follow-Up Tests of Leading Personal Care and Household Cleaning Brands Reveal Significant Improvements in Levels of Carcinogenic 1,4-dioxane

...ss conference on 1,4-dioxane in "Natural" and "Organic" Personal Care and Household Cleaning Products WHEN: Friday, March 6, 2009, 9:00 a.m. pst to coincide with the Natural Products Expo West WHERE: Anaheim Hilton, 777 Convention Way, Anaheim CA, 92802, Coronado Room 4th Floor ...

Hope is Not a Strategy: Neither is Web 2.0 for a Hospital

...ategy hospitals need to implement to ensure success. Join us for the next reThinking eHealth Webinar on Wednesday, January 28th at 2pm EST / 11am pst to get details about eHealth 3.0. In addition, MEDSEEK clients and industry experts will shed light on when, where and how to use Web 2.0 tools and wh...

Omnicell to Release Fourth Quarter 2008 Earnings Results on January 29

...load necessary audio software. Replay: Available starting at 2:30 p.m. pst on January 29, 2009 through 8:59 p.m. pst on February 5. Dial 1-800-642-1687 within the U.S. and 1-706-...

Omnicell Updates 2008 Year End Guidance and Announces Company Reorganization

...ell.com . A replay of the call will be available at approximately 9:00 a.m. pst on January 21, 2009 through 1:59 p.m. pst on January 28. The replay access numbers are 1-800-642-1687 within the U.S....

Lumension Security Webinar Focuses on Security Mega Trends and Emerging Threats in 2009

... in a challenging business environment. Event Details: WHAT: Security Mega Trends and Emerging Threats for 2009 WHEN: January 15, 2009; 8:00 am pst / 11:00 am EST WHO: Dr. Larry Ponemon, Chairman and Founder of the Ponemon Institute, Paul Henry, Security and Forensic Analyst, and Ed Brice, Senior...

PST in Medical Technology

More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies

...1 & 446 ; Monday, December 8, 2008; 7:00 AM pst & 1:45 PM PST, respectively) Cardiac ... Abstract #335: Monday, December 8, 2008; 12:00 PM pst ) International Randomized Study of Interf...H Abstract #186: Monday, December 8, 2008; 8:15 AM pst ) Exjade ...

Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers

...f a Phase I Safety, Tolerability and Pharmacokinetic Study of ANA598, a Non-Nucleoside NS5B Polymerase Inhibitor, in Healthy Volunteers", at 1:00 p.m. pst on Monday, November 3. ANA598 Preclinical Data at AASLD Meeting In addition to the results of the Phase I healthy volunteer study, Anadys is prese...

CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years

...rding to Studies Presented at American College of Rheumatology (ACR) Annual Scientific Meeting SAN FRANCISCO, Oct. 27 /PRNewswire/ -- 5:00 AM pst -- UCB announced today results from several Phase III clinical trials evaluating CIMZIA(R) (certolizumab pegol) - the only PEGylated anti-TNF (Tumor N...

Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients

...d below, can be viewed at the AASLD website at http://www.aasld.org . Anadys will present a late-breaker poster at a session beginning at 8:00 a.m. pst on Monday, November 3. The poster, titled "Results of a Phase I Safety, Tolerability and Pharmacokinetic Study of ANA598, a Non-Nucleoside NS5B Polyme...

Clinical Experience With Peregrine's Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents

...ulature Antibody, Bavituximab," is part of the Angio 2008 session on Early Drug Development/Clinical Trial Results being held from 8:00 am to 12:00 pm pst at the 10th Annual International Symposium on Anti-Angiogenic Agents at the Hyatt Regency Hotel in La Jolla, CA. About Peregrine Pharmaceuticals P...

Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study

...al) 10 minutes prior to the start time and use the passcode 54253199. A replay of the call will be available at approximately 2:30 p.m. EST/11:30 a.m. pst on December 13, 2007 until December 20, 2007. To access the replay, please dial 888-286-8010 (domestic) or 617-801-6888 (international) and use the pa...

Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble

...tech management will host a conference call to discuss its development plans for teriparatide nasal spray. The call is scheduled for 8 a.m. EST/5 a.m. pst today, Wednesday, Nov. 7. To participate in the live conference call, U.S. callers should dial (866) 510-0711, and international callers should dial (...

Six-Week Investigational Study In Adults With Major Depressive Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole Therapy With Antidepressants

...ation at: annual meeting of the American Psychiatric Association, San Diego, California, Monday, May 21, 2007, 3:00 p.m. - 5:00 p.m. pst - Poster Session 3. (2) Diagnostic and Statistical Manual of Mental Disorders. Fourth ed-TR. Psychiatry Online Web site. Avail...

Investigational Study Evaluates the Effectiveness of Aripiprazole in Adolescents With Schizophrenia

... San Diego, California, Wednesday, May 23, 2007, 3:00 p.m. - 5:00 p.m. pst - Poster Session 7. (2) Findling RL, Nyilas M, Auby P, Mallikaar... San Diego, California, Wednesday, May 23, 2007, 3:00 p.m. - 5:00 p.m. pst - Poster Session 7. (3) IMS Auditrac NGPS: Abilify total monthly reta...

PST in Biological Technology

Executive Coaching Firm Mariposa Leadership, Inc. Hosts Webinar to Help Business Leaders Navigate Tumultuous Economy

...r, "Managing Fear and Uncertainty: How to Take Back Control of Your Business in this Rollercoaster Economy," takes place from 10 AM to 11 AM pst on May 13, 2009. Sue Bethanis, CEO and founder of Mariposa Leadership, Inc., will coach participants on how to discern exactly what it is they fear, s...

Accuray Incorporated to Report Second Quarter Fiscal Year 2009 Financial Results

...call to review the results will begin at 2:00 p.m. pst / 5:00 p.m. EST and will be hosted by Euan S. Thom... available beginning January 29, 2009 at 5:00 p.m. pst / 8:00 p.m. EST and ending on January 31, 2009. Th...rsday, January 29, 2009 at approximately 5:00 p.m. pst / 8:00 p.m. EST. The replay will remain available...

ImmunoVaccine Technologies Presents at OneMed Place Finance Forum

... CA. For more information visit www.onemedplace.com . Dr. Randal Chase, president and CEO of ImmunoVaccine Technologies Inc., will speak at 8:45 am pst on the development of its superior vaccine delivery system, DepoVax(TM). DepoVax(TM) is being used to develop a single-dose rapid response pandemic in...

Nuvelo Shareholders Approve Issuance of Common Stock Pursuant to Merger Agreement With ARCA biopharma

...e to solicit additional proxies on the proposal authorizing the reverse stock split. The Nuvelo stockholder meeting will reconvene at 9:00 a.m. pst on January 23, 2009 at Nuvelo's corporate headquarters located at 201 Industrial Road, Suite 310, San Carlos, California to consider the proposal to a...

Par Pharmaceutical to Present at the 27th Annual J.P. Morgan Healthcare Conference

...maceutical Companies, Inc. (NYSE: PRX ) will be presenting at the 27th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, at 3:00 pm pst at the Westin St. Francis Hotel. The audio-only live webcast will be accessible through the J.P. Morgan website at http://metameetings.com/web...

Accuray Incorporated's CEO to Speak at 27th Annual JP Morgan Healthcare Conference

...mson, Ph.D., is scheduled to present at the 27th Annual JP Morgan Healthcare Conference in San Francisco, on Wednesday, January 14, 2009 at 11:30 a.m. pst (2:30 p.m. EST). A live webcast of the presentation will be available online from the investor relations page of the Company's Web site at htt...

Rigel to Host Conference Call to Discuss Phase 2 Study Results of R788 in Lymphoma Presented at ASH

...ll be available, in webcast and podcast formats, at approximately 6:00 p.m. pst on December 7, 2008 through December 14, 2008. To access the replay, please...ation Details Plenary session: Sunday, December 7, 2008 - 2:40 p.m. pst Title: 3 - Fostamatinib Disodium (FosD), An Oral Inhibitor of Syk, ...

KGI Entrepreneur Program Hosts Angel Investing Educational Meeting

...wth companies in Southern California, is open to members of the public interested in becoming angel investors. The educational session begins at 3 pm pst on the KGI campus. To attend or learn more about angel investing and TCA, send an email to TCA at InlandEmpire@techcoastangels.com " target="_new"> ...

Interleukin Genetics Reports Third Quarter 2008 Financial Results

...a new license agreement with OralDNA to market our pst Genetic Test as an assessment of risk for periodon...additional channels of its choosing. -- Licensed pst Genetic Test to OralDNA Labs, Inc.: In August 2008...les and distribution agreement for its proprietary pst genetic risk assessment test for use in the diagno...

Genmab A/S: Ofatumumab Pivotal CLL Data to be Presented at ASH

...l three ofatumumab abstracts are available on the ASH website at http://www.hematology.org . ASH Sessions Oral Presentation December 8 at 11:45AM pst - Ofatumumab (HuMax-CD20), a Novel CD20 Monoclonal Antibody, Is An Active Treatment for Patients with CLL Refractory to Both Fludarabine and Alemtuzum...